Eur Rev Med Pharmacol Sci 2024; 28 (10): 3476-3476
DOI: 10.26355/eurrev_202405_36279

Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1

J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu

Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China


The article “MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1”, by J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 639-646–DOI: 10.26355/eurrev_202001_20040–PMID: 32017004 has been retracted by the Editor in Chief.

Following some concerns raised on PubPeer regarding a possible overlap in Figure 2C, the journal has started an investigation to assess the validity of the results as well as possible figure manipulation.

The journal investigation revealed data and figure manipulation. For this reason, the Editor in Chief has decided to retract the manuscript.

 

The authors have been informed about the retraction but remained unresponsive.

 

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1

Free PDF Download

To cite this article

J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu
Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 10
Pages: 3476-3476
DOI: 10.26355/eurrev_202405_36279